RI
Ridgewood Investments Portfolio holdings
AUM
$231M
This Quarter Return
+4.17%
1 Year Return
+17.35%
3 Year Return
+46.12%
5 Year Return
+86.39%
10 Year Return
–
AUM
$93.1M
AUM Growth
+$93.1M
(+9.7%)
Cap. Flow
+$4.9M
Cap. Flow
% of AUM
5.27%
Top 10 Holdings %
Top 10 Hldgs %
37.51%
Holding
135
New
18
Increased
57
Reduced
40
Closed
2
Top Buys
| 1 |
General Motors
GM
|
$390K |
| 2 |
Federated Hermes
FHI
|
$309K |
| 3 |
Compass Minerals
CMP
|
$300K |
| 4 |
Flowserve
FLS
|
$271K |
| 5 |
Kimberly-Clark
KMB
|
$265K |
Top Sells
| 1 |
Berkshire Hathaway Class B
BRK.B
|
$246K |
| 2 |
McDonald's
MCD
|
$223K |
| 3 |
LDL
Lydall, Inc.
LDL
|
$212K |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
$89.9K |
| 5 |
Invesco S&P International Developed Low Volatility ETF
IDLV
|
$74.3K |
Sector Composition
| 1 | Financials | 31.28% |
| 2 | Industrials | 12.89% |
| 3 | Healthcare | 9.38% |
| 4 | Consumer Staples | 5.26% |
| 5 | Technology | 5.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PBCT
101
DELISTED
People's United Financial Inc
PBCT
| $265K | 0.28% | 14,538 +1,943 | +15% | +$35.4K |
|
102
Teva Pharmaceuticals
TEVA
$21.1B
| $259K | 0.28% | 8,063 +1,007 | +14% | +$32.3K |
|
103
Accenture
ACN
$162B
| $257K | 0.28% | 2,141 -249 | -10% | -$29.9K |
|
104
Northern Trust
NTRS
$25B
| $255K | 0.27% | 2,940 +1 | +0% | +$87 |
|
105
Applied Industrial Technologies
AIT
$9.95B
| $254K | 0.27% | 4,106 -14 | -0.3% | -$866 |
|
106
CSX Corp
CSX
$60.6B
| $252K | 0.27% | +5,407 | New | +$252K |
|
|
TUZ
107
DELISTED
PIMCO 1-3 Year U.S. Treasury Index Exchange-Traded Fund
TUZ
| $251K | 0.27% | 4,951 +118 | +2% | +$5.98K |
|
|
EBIX
108
DELISTED
Ebix Inc
EBIX
| $251K | 0.27% | 4,103 | – | – |
|
109
Invesco Bloomberg MVP Multi-factor ETF
BMVP
$112M
| $246K | 0.26% | 2,933 +1 | +0% | +$84 |
|
110
Cullen/Frost Bankers
CFR
$8.3B
| $241K | 0.26% | 2,711 -6 | -0.2% | -$533 |
|
111
GE Aerospace
GE
$292B
| $240K | 0.26% | +8,046 | New | +$240K |
|
112
Gilead Sciences
GILD
$140B
| $237K | 0.25% | +3,496 | New | +$237K |
|
113
Eli Lilly
LLY
$657B
| $237K | 0.25% | 2,812 -6 | -0.2% | -$506 |
|
114
Zimmer Biomet
ZBH
$21B
| $237K | 0.25% | +1,939 | New | +$237K |
|
|
CELG
115
DELISTED
Celgene Corp
CELG
| $237K | 0.25% | 1,903 +1 | +0.1% | +$125 |
|
116
Intel
INTC
$107B
| $227K | 0.24% | +6,297 | New | +$227K |
|
117
Dover
DOV
$24.5B
| $222K | 0.24% | 2,757 +1 | +0% | +$81 |
|
118
GSK
GSK
$79.9B
| $222K | 0.24% | +5,256 | New | +$222K |
|
119
Baxter International
BAX
$12.7B
| $220K | 0.24% | +4,250 | New | +$220K |
|
120
AptarGroup
ATR
$9.18B
| $219K | 0.24% | 2,840 +1 | +0% | +$77 |
|
121
Exelon
EXC
$44.1B
| $218K | 0.23% | 6,060 | – | – |
|
122
AT&T
T
$209B
| $212K | 0.23% | +5,093 | New | +$212K |
|
123
SPDR Gold Trust
GLD
$107B
| $207K | 0.22% | 1,743 -85 | -5% | -$10.1K |
|
124
Vanguard Real Estate ETF
VNQ
$34.6B
| $203K | 0.22% | +2,460 | New | +$203K |
|
125
Booking.com
BKNG
$181B
| $202K | 0.22% | +113 | New | +$202K |
|